Singapore markets closed

Acticor Biotech SAS (ALACT.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
0.7580+0.0280 (+3.84%)
At close: 02:29PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-18,649
-15,878
-12,608
-7,651
-5,053
Depreciation & amortisation
133
86
96
99
502
Stock-based compensation
670
1,045
375
323
276
Change in working capital
3,159
2,748
-2,415
492
161
Other working capital
-13,777
-12,110
-13,763
-6,794
-4,293
Other non-cash items
-760
433
646
-44
39
Net cash provided by operating activities
-13,761
-12,104
-13,750
-6,741
-4,276
Cash flows from investing activities
Investments in property, plant and equipment
-16
-6
-13
-53
-17
Purchases of investments
-89
-66
0
-
-
Sales/maturities of investments
6
6
0
-
-
Other investing activities
-
-
1
-
344
Net cash used for investing activities
-96
-66
-12
-53
326
Net change in cash
3,061
-4,749
3,761
-5,296
2,694
Cash at beginning of period
4,894
11,348
7,587
12,883
10,188
Cash at end of period
7,955
6,599
11,348
7,587
12,882
Free cash flow
Operating cash flow
-13,761
-12,104
-13,750
-6,741
-4,276
Capital expenditure
-16
-6
-13
-53
-17
Free cash flow
-13,777
-12,110
-13,763
-6,794
-4,293